- Home
- MCD vs NVS Comparison
MCD vs NVS Comparison
Compare MCD & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCD
- NVS
- Stock Information
- Founded
- MCD 1940
- NVS 1895
- Country
- MCD United States
- NVS Switzerland
- Employees
- MCD N/A
- NVS N/A
- Industry
- MCD Restaurants
- NVS Biotechnology: Pharmaceutical Preparations
- Sector
- MCD Consumer Discretionary
- NVS Health Care
- Exchange
- MCD Nasdaq
- NVS Nasdaq
- Market Cap
- MCD 229.5B
- NVS 230.5B
- IPO Year
- MCD N/A
- NVS 1991
- Fundamental
- Price
- MCD $312.24
- NVS $111.45
- Analyst Decision
- MCD Buy
- NVS Hold
- Analyst Count
- MCD 26
- NVS 6
- Target Price
- MCD $324.08
- NVS $123.67
- AVG Volume (30 Days)
- MCD 3.6M
- NVS 2.5M
- Earning Date
- MCD 04-29-2025
- NVS 04-29-2025
- Dividend Yield
- MCD 2.27%
- NVS 2.94%
- EPS Growth
- MCD N/A
- NVS N/A
- EPS
- MCD 11.39
- NVS 5.87
- Revenue
- MCD $25,920,000,000.00
- NVS $51,722,000,000.00
- Revenue This Year
- MCD $3.28
- NVS $4.36
- Revenue Next Year
- MCD $5.28
- NVS $1.93
- P/E Ratio
- MCD $27.42
- NVS $18.99
- Revenue Growth
- MCD 1.67
- NVS 10.85
- 52 Week Low
- MCD $243.53
- NVS $92.35
- 52 Week High
- MCD $326.32
- NVS $120.92
- Technical
- Relative Strength Index (RSI)
- MCD 56.82
- NVS 53.59
- Support Level
- MCD $304.03
- NVS $108.65
- Resistance Level
- MCD $316.64
- NVS $112.85
- Average True Range (ATR)
- MCD 5.43
- NVS 1.35
- MACD
- MCD 0.26
- NVS -0.26
- Stochastic Oscillator
- MCD 78.98
- NVS 66.38
About MCD McDonald's Corporation
McDonald's is the largest restaurant owner-operator in the world, with 2024 system sales of $131 billion across more than 43,000 stores and 115 markets. McDonald's pioneered the franchise model, building its footprint through partnerships with independent restaurant franchisees and master franchise partners around the globe. The firm earns roughly 60% of its revenue from franchise royalty fees and lease payments, with most of the remainder coming from company-operated stores across its three core segments: the United States, internationally operated markets, and international developmental/licensed markets.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.